Related Experiment Video
Updated: Feb 18, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Alzheimer's Disease-Current Status and Future Directions.
Deepshikha Bhardwaj1, Connie Mitra1, Chandrakala Aluganti Narasimhulu1
1Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida , Orlando, Florida, USA.
Alzheimer's disease (AD) is a neurodegenerative disorder linked to genetic factors like apolipoprotein E ɛ4 and oxidative stress. This review explores AD causes, pathophysiology, and nutritional antioxidant therapies for treatment.
Area of Science:
- Neurodegenerative Disorders
- Genetics of Aging
- Alzheimer's Disease Pathophysiology
Background:
- Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques, neurofibrillary tangles (NFTs), neuronal loss, and memory impairment.
- The exact cause of AD remains unclear, though genetic and non-genetic factors are implicated, with the apolipoprotein E ɛ4 allele being a significant genetic risk factor.
- Oxidative stress is increasingly recognized as a contributing factor in AD etiology.
Purpose of the Study:
- To review the genetic and predisposing factors contributing to Alzheimer's disease.
- To elucidate the pathophysiology of AD, including the formation mechanisms of Aβ plaques and NFTs.
- To detail recent diagnostic advances and explore nutrition-based antioxidant therapies for AD intervention.
Main Methods:
- Literature review focusing on genetic factors, AD pathophysiology, plaque and tangle formation.
- Analysis of current diagnostic tools and advancements for Alzheimer's disease.
- Examination of oxidative stress and its role, with emphasis on antioxidant therapies.
Main Results:
- Apolipoprotein E ɛ4 is identified as a major genetic risk factor for AD.
- The review details mechanisms of Aβ plaque and NFT formation and their impact on the AD brain.
- Current diagnostic methods and emerging nutritional antioxidant strategies are presented.
Conclusions:
- Understanding genetic and predisposing factors is crucial for AD research.
- Targeting Aβ plaques, NFTs, and oxidative stress, potentially through nutrition, offers therapeutic avenues.
- Continued research into AD causes, diagnostics, and interventions is essential for effective management.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Overview
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

